Literature DB >> 3941369

Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart.

M Nakajo, K Shimabukuro, H Yoshimura, R Yonekura, Y Nakabeppu, P Tanoue, S Shinohara.   

Abstract

In order to establish the appropriate time for [123I]MIBG human myocardial imaging to assess the adrenergic nerve activity, the time courses of metaiodobenzylguanidine (MIBG) intra- and extravesicular accumulation in the rat heart were estimated by using [131I]MIBG and reserpine. In the heart, the intravesicular accumulation was relatively constant, while the extravesicular accumulation decreased rapidly from 5 min to 6 hr. The intravesicular percentage of the total cardiac tissue concentration reached a plateau value of 50% at 4 hr after i.v. injection of [131I]MIBG. In the spleen, similar time courses were observed as those in the heart, both of these organs being richly innervated by adrenergic nerves. Along with the time activity difference previously observed in the human hearts, these results suggest that at 4 hr post i.v. injection, [123I]MIBG myocardial imaging will best express the neuronal accumulation of the tracer and may be useful for the assessment of adrenergic function in various pathological conditions of the human heart.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941369

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  35 in total

Review 1.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

2.  Interaction of metaiodobenzylguanidine with cardioactive drugs: an in vitro study.

Authors:  F Huguet; D Fagret; M Caillet; A Piriou; J C Besnard; D Guilloteau
Journal:  Eur J Nucl Med       Date:  1996-05

3.  Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy.

Authors:  K Yamakado; K Takeda; T Kitano; T Nakagawa; Y Futagami; T Konishi; M Hamada; T Nakano; T Ichihara
Journal:  Eur J Nucl Med       Date:  1992

4.  Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct.

Authors:  D Fagret; J E Wolf; M Comet
Journal:  Eur J Nucl Med       Date:  1989

5.  Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction.

Authors:  M Toyono; C Kondo; Y Nakajima; M Nakazawa; K Momma; K Kusakabe
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

6.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02

7.  Serial assessment of denervated but viable myocardium following acute myocardial infarction in dogs using iodine-123 metaiodobenzylguanidine and thallium-201 chloride myocardial single photon emission tomography.

Authors:  T Nishimura; H Oka; M Sago; T Matsuo; T Uehara; H Noda; H Takano
Journal:  Eur J Nucl Med       Date:  1992

Review 8.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

9.  Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus.

Authors:  M Mäntysaari; J Kuikka; J Mustonen; K Tahvanainen; E Vanninen; E Länsimies; M Uusitupa
Journal:  Clin Auton Res       Date:  1996-06       Impact factor: 4.435

10.  Influence of prolonged exercise on myocardial distribution of 123I-MIBG in long-distance runners.

Authors:  M Estorch; R Serra-Grima; I Carrió; A Flotats; A Lizárraga; L L Bernà; T Prats; R Segura
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.